Tags: Cefzil

Urinary Tract Infections and Prostatitis

Definition Infections of the urinary tract represent a wide variety of clinical syndromes including urethritis, cystitis, prostatitis, and pyelonephritis. A urinary tract infection is defined as the presence of microorganisms in the urine that cannot be accounted for by contamination. The organisms have the potential to invade the tissues of the urinary tract and adjacent structures. Lower tract infections include cystitis (bladder), urethritis (urethra), prostatitis (prostate gland), and epididymitis. Upper tract infections involve the kidney and are referred to as pyelonephritis. Uncomplicated urinary tract infections are not associated with structural or neurologic abnormalities that may interfere with the normal flow of urine or the voiding mechanism. Complicated urinary tract infections are …

Continue Reading...

Antimicrobial therapy: general principles

A wide variety of antimicrobial agents is available to treat established infections caused by bacteria, fungi, viruses, or parasites. This section will cover the general principles of antimicrobial therapy and will also include illustrative clinical problems to emphasize proper decision-making in using antimicrobials. Determinants of Antimicrobial Efficacy Measurement of antimicrobial activity in vitro Susceptibility testing is indicated for any bacterial pathogen warranting chemotherapy. Drugs that irreversibly destroy the ability of an organism to replicate, and perhaps in the process destroy the structural integrity of the organism, are microbicidal. Drugs that reversibly impair replicating ability, with this function being restored when drug concentrations fall below critical inhibitory levels, are microbiostatic. In quantitative …

Continue Reading...

Cefprozil

• Cefprozil is a semisynthetic, second generation cephalosporin antibiotic. Uses Cefprozil is used orally for the treatment of mild to moderate respiratory tract infections (i.e., acute sinusitis, secondary bacterial infections of acute bronchitis, acute exacerbations of chronic bronchitis, community-acquired pneumonia) caused by susceptible bacteria. The drug also is used orally for the treatment of acute otitis media caused by susceptible bacteria, pharyngitis and tonsillitis caused by Streptococcus pyogenes (group A b-hemolytic streptococci), and mild to moderate uncomplicated skin and skin structure infections caused by susceptible bacteria. • Respiratory Tract Infections • Acute Sinusitis Oral cefprozil is used in adults and children 6 months of age or older for the treatment of …

Continue Reading...

Community-Acquired Pneumonia: Current Therapies

Overview Many highly effective agents are available for the treatment of bacterial community-acquired pneumonia (community-acquired pneumonia) and other community-acquire respiratory tract infections (RTIs). Currently marketed antibiotics for community-acquired pneumonia demonstrate similar efficacy rates in clinical trials, and these agents have generally achieved clinical symptom resolution in 85-95% of trial participants. The drugs differ mainly in their spectrum of activity (the organisms against which the agent is effective), side-effect profiles, dosing schedules, and dose form availability. Broad-spectrum antibiotics are effective against a wide range of pathogens; narrow-spectrum antibiotics tend to be efficacious against a narrower range of bacterial species, generally either gram-positive or gram-negative organisms.TABLE:Mechanisms of Resistance Against Select Antibacterial Classes, 2004 …

Continue Reading...

Buy Cefprozil, Ceftin Online Without Prescription

Cefuroxime Axetil. Cefprozil Cefuroxime Axetil Cefuroxime axetil (GSK’s Ceftin/Zinnat/Oracef) is a second-generation cephalosporin consisting of an esterified pro-drug of cefuroxime created for oral formulation; the active antibiotic metabolite cefuroxime is released after cefuroxime axetil absorption from the gastrointestinal tract. First launched in the United States in 1988, cefuroxime axetil was available as a generic in the United States by 2002. Cefuroxime is active against a broad spectrum of gram-positive and gram-negative bacteria, including Staphylococcus aureus, Streptococcus pneumoniae, Streptococcus pyogenes, E. coli, H. influenzae, K. pneumoniae, and M. catarrhalis. Cefuroxime axetil is indicated for a number of bacterial infections, including RTIs caused by β-lactam  ase-negative strains of S. pneumoniae, H. influenzae, M. …

Continue Reading...

Buy Cefuroxime (Ceftin) No Prescription 125/250/500mg

Cefuroxime Axetil. Cefprozil. Cefpodoxime Proxetil Cefuroxime Axetil Cefuroxime axetil (GlaxoSmithKline’s Ceftin/Zinnat/ Oracef) * is a second-generation oral cephalosporin consisting of an esterified pro-drug of cefuroxime; the active antibiotic metabolite cefuroxime is released following cefuroxime axetil absorption from the GI tract. First launched in the United States in 1988, cefuroxime axetil was available as a U.S. generic by 2002. This product is active against a broad spectrum of gram-positive and gram-negative bacteria, including S. pneumoniae, H. influenza, K. pneumoniae, and M. catarrhalis. Cefuroxime axetil is indicated for a number of bacterial infections including respiratory tract infections caused by β-lactamase-negative strains of S. pneumoniae, H. influenzae, M. catarrhalis, and Haemophilusparainfluenzae. The agent’s efficacy …

Continue Reading...

Acute Exacerbations of Chronic Bronchitis: Current therapies

Overview Numerous highly effective pharmacological agents are available to treat acute exacerbations of chronic bronchitis (acute exacerbations of chronic bronchitis). TABLE:Pharmacological Management of Underlying Disease During an Acute Exacerbation of Chronic Bronchitis summarizes the general pharmacological agents and classes used to manage acute exacerbations of chronic bronchitis. The primary therapies used in acute exacerbations of chronic bronchitis treat the causative infection (antibiotics), relieve symptoms (bronchodilators), and treat the underlying inflammation (corticosteroids). TABLE :Current Therapies Used for Acute Exacerbations of Chronic Bronchitis summarizes the leading antibiotic therapies used to treat the infection. Most acute exacerbations of chronic bronchitis cases require empiric antibiotic therapy because of the difficulty in definitively distinguishing exacerbations of …

Continue Reading...
CLOSE
CLOSE